Upregulation of osteopontin gene expression in diabetic rat proximal tubular cells revealed by microarray profiling

Kidney International

Volumn 69, Issue 6, 2006, Pages 1005-1015

  Hsieh, T J ^a,d   Chen, R ^a   Zhang, S L ^a   Liu, F ^a   Brezniceanu, M L ^a   Whiteside, C I ^b   Fantus, I G ^b   Ingelfinger, J R ^c   Hamet, P ^a   Chan, J S D ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

High glucose; Osteopontin; Renin angiotensin system

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN II; CALPHOSTIN C; COMPLEMENTARY DNA; DIPHENYLIODONIUM SALT; GLUCOSE; LOSARTAN; LY 379196; MESSENGER RNA; OSTEOPONTIN; PERINDOPRIL; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C BETA; PROTEIN KINASE C BETA1; REACTIVE OXYGEN METABOLITE; TAURINE; TIRON; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL IMMORTALIZATION; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE COURSE; DNA MICROARRAY; DOSE RESPONSE; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; KIDNEY INJURY; KIDNEY PROXIMAL TUBULE; LONG TERM EXPOSURE; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; RAT STRAIN; REAL TIME POLYMERASE CHAIN REACTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STREPTOZOCIN DIABETES;

ANGIOTENSIN II; ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; GENE EXPRESSION; GENE EXPRESSION PROFILING; GLUCOSE; GLYCOPROTEINS; KIDNEY TUBULES, PROXIMAL; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEIN KINASE C; RATS; RATS, INBRED BB; RATS, WISTAR; REACTIVE OXYGEN SPECIES; RENIN-ANGIOTENSIN SYSTEM; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; TETRADECANOYLPHORBOL ACETATE; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; UP-REGULATION;

EID: 33644853133     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5000206     Document Type: Article

References (51)

1. Gilbert RE, Cooper ME. The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury? Kidney Int 1999; 56: 1627-1637.
2. Phillips AO, Steadman R. Diabetic nephropathy: the central role of renal proximal tubular cells in tubulointerstitial injury. Histol Histopathol 2002; 17: 247-252.
3. Phillips AO. The role of renal proximal tubular cells in diabetic nephropathy. Curr Diab Rep 2003; 3: 491-496.
4. Bach LA, Jerums G. Effect of puberty on initial kidney growth and rise in kidney IGF-I in diabetic rats. Diabetes 1990; 39: 557-562.
5. Gilbert RE, Cox A, McNally PG et al. Increased epidermal growth factor expression in diabetes related kidney growth. Diabetologia 1997; 40: 778-785.
6. Benigni A, Colosio W, Brena C et al. Unselective inhibition of endothelin receptors reduces renal dysfunction in experimental diabetes. Diabetes 1998; 47: 450-456.
7. Sharma K, Ziyadeh FN. Renal hypertrophy is associated with upregulation of TGF-beta 1 gene expression in diabetic BB rat and NOD mouse. Am J Physiol 1994; 267: F1094-F1101.
8. Wolf G, Mueller E, Stahl RAK, Ziyadeh FN. Angiotensin II-induced hypertrophy of cultured murine proximal tubular cells is mediated by endogenous transforming growth factor-β. J Clin Invest 1993; 92: 1366-1372.
9. Sharma K, Jin Y, Guo J, Ziyadeh FN. Neutralization of TGF-beta by TGF-beta antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice. Diabetes 1996; 45: 522-530.
10. Han DC, Hoffman BB, Hone SW et al. Therapy with antisense TGF-beta 1 oligodeoxynucleotides reduces kidney weight and matrix mRNA in diabetic mice. Am J Physiol 2000; 278: F628-F634.
11. Wada J, Zhang H, Tsuchiyama Y et al. Gene expression profile in streptozotocin-induced diabetic mice kidneys undergoing glomerulosclerosis. Kidney Int 2001; 59: 1363-1373.
12. Goruppi S, Bonventre JV, Kyriakis JM. Signaling pathways and late-onset gene induction associated with renal mesangial cell hypertrophy. EMBO J 2002; 21: 5427-5436.
13. Fan Q, Shike T, Shigihara T et al. Gene expression profile in diabetic KK/Ta mice. Kidney Int 2003; 64: 1978-1985.
14. Wilson KH, Eckenrode SE, Li QZ et al. Microarray analysis of gene expression in the kidneys of new- and post-onset diabetic NOD mice. Diabetes 2003; 52: 2151-2159.
15. Baelde HJ, Eikmans M, Doran PP et al. Gene expression profiling in glomeruli from human kidneys with diabetic nephropathy. Am J Kidney Dis 2004; 43: 636-650.
16. Susztak K, Bottinger E, Novetsky A et al. Molecular profiling of diabetic mouse kidney reveals novel genes linked to glomerular disease. Diabetes 2004; 53: 784-794.
17. Brown LF, Berse B, Van de Water L et al. Expression and distribution of osteopontin in human tissues: widespread association with luminal epithelial surfaces. Mol Biol Cell 1992; 3: 1169-1180.
18. Mazzali M, Kipari T, Ophascharoensuk V et al. Osteopontin - a molecule for all seasons. Q J Med 2002; 95: 3-13.
19. Gilbert RE. Progression of tubulointerstitial injury by osteopontin-induced recruitment in advanced diabetic nephropathy of transgenic (mRen-2) 27 rats. Nephrol Dial Transplant 2002; 17: 985-991.
20. Li C, Yang CW, Park CW et al. Long-term treatment with ramipril attenuates renal osteopontin expression in diabetic rats. Kidney Int 2003; 63: 454-463.
21. Diamond JR, Kriesberg R, Evans R et al. Regulation of proximal tubular osteopontin in experimental hydronephrosis in the rat. Kidney Int 1998; 54: 1501-1509.
22. Ricardo SD, Franzoni DF, Roesner CD et al. Angiotensinogen and AT(1)R inhibition of osteopontin translation in rat proximal tubular cells. Am J Physiol Renal Physiol 2000; 278: F708-F716.
23. Giachelli CM, Pichler R, Lombardi D et al. Osteopontin expression in angiotensin II-induced tubulointerstitial nephritis. Kidney Int 1994; 45: 515-524.
24. Pichler R, Giachelli CM, Lombardi D et al. Tubulointerstitial disease in glomerulonephritis: potential role of osteopontin. Am J Pathol 1994; 144: 915-926.
25. Denhardt DT, Noda M, O'Regan AW et al. Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival. J Clin Invest 2001; 107: 1055-1061.
26. Fischer JW, Tschope C, Reinecke A et al. Upregulation of osteopontin expression in renal cortex of streptozotocin-induced diabetic rats is mediated by bradykinin. Diabetes 1998; 47: 1512-1518.
27. Junaid A, Amara FM. Osteopontin: correlation with interstitial fibrosis in human diabetic kidney and PI3-kinase-mediated enhancement of expression by glucose in human proximal tubular epithelial cells. Histopathology 2004; 44: 136-146.
28. Xie Y, Sakatsume M, Nishi S et al. Expression, roles, receptors, and regulation of osteopontin in the kidney. Kidney Int 2002; 60: 1645-1657.
29. Nishikawa T, Edelstein D, Du XL et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycemia damage. Nature 2000; 404: 787-790.
30. Brownlee M. Biochemistry and molecular biology of diabetic complications. Nature 2001; 414: 813-820.
31. Zhang S-L, Filep JA, Hohman TC et al. Molecular mechanisms of glucose action on angiotensinogen gene expression in rat proximal tubular cells. Kidney Int 1999; 55: 454-464.
32. Hsieh TJ, Zhang SL, Filep JG et al. High glucose stimulates angiotensinogen gene expression via reactive oxygen species generation in rat kidney proximal tubular cells. Endocrinology 2002; 143: 2975-2985.
33. Xie Z, Pimentai DR, Lohan S et al. Regulation of angiotensin II-stimulated osteopontin expression in cardiac microvascular endothelial cells: role of p42/44 mitogen-activated protein kinase and reactive oxygen species. Cell Physiol 2001; 188: 132-138.
34. Tucker MA, Chang PL, Prince CW et al. TPA-mediated regulation of osteopontin in human malignant glioma cells. Anticancer Res 1998; 18: 807-812.
35. Sodhi CP, Phadke SA, Batlle D, Sahai A. Hypoxia stimulates osteopontin expression and proliferation of cultured vascular smooth muscle cells: potentiation by high glucose. Diabetes 2001; 50: 1482-1490.
36. Chang PL, Tucker MA, Hicks PH, Prince CW. Novel protein kinase C isoforms and mitogen-activated kinase kinase mediate phorbol ester-induced osteopontin expression. Int J Biochem Cell Biol 2002; 34: 1142-1151.
37. Kelly DJ, Chanty A, Gow RM et al. Protein kinase Cβ attenuates osteopontin expression, macrophage recruitment, and tubulointerstitial injury in advanced experimental diabetic nephropathy. J Am Soc Nephrol 2005; 16: 1654-1660.
38. Malyankar UM, Almeida M, Johnson RJ et al. Osteopontin regulation in cultured rat renal epithelial cells. Kidney Int 1997; 51: 1766-1773.
39. Bandyopadhyay G, Standaert ML, Kikkawa U et al. Effects of transiently expressed atypical (ζ, λ), conventional (α, β) and novel (δ, ε) protein kinase C isoforms on insulin-stimulated translocation of epitope-tagged GLUT 4 glucose transporters in rat adipocytes: specific interchangeable effects of protein C-ζ and C-λ. Biochem J 1999; 337: 461-470.
40. Qian SW, Kondaiah P, Roberts AB, Sporn MB. cDNA cloning of rat transforming growth factor-beta 1. Nucleic Acids Res 1990; 18: 3059.
41. Field CJ, Butler SC. The BB rat: a unique model of human type I diabetes. In: McNeill JH (ed). Experimental Models of Diabetes. Boca Raton, FL: CRC Press LLC, 1999, Chapter 13, pp 295-318.
42. Nakhooda AF, Like AA, Chappel CI et al. The spontaneously diabetic Wistar rat. Metabolic and morphologic studies. Diabetes 1977; 26: 100-112.
43. Nakhooda AF, Wei CN, Marliss EB. Muscle protein catabolism in diabetes: 3-methylhistidine excretion in the spontaneously diabetic 'BB' rat. Metabol: Clin Exp 1980; 29: 1272-1277.
44. Marliss EB. Recommended nomenclature for the spontaneously diabetic syndrome of the BB rat. Metabol: Clin Exp 1983; 32(7 Suppl 1): 6-7.
45. Zhang S-L, Chen X, Hsieh T-J et al. Hyperglycemia induces insulin resistance on angiotensinogen gene expression in diabetic rat kidney proximal tubular cells. J Endocrinol 2002; 172: 333-344.
46. Vinay P, Gougoux A, Lemieux G. Isolation of a pure suspension of rat proximal tubules. Am J Physiol 1981; 241: F403-F411.
47. Ingelfinger JR, Jung F, Diamond D et al. Rat proximal tubular cell line transformed with origin-defective SV40 DNA: autocrine Ang II feedback. Am J Physiol 1999; 276: F218-F227.
48. Zhang SL, To C, Chen X et al. Essential role(s) of the intrarenal rennin-angiotensin system in transforming growth factor-beta 1 gene expression and induction of hypertrophy of rat kidney proximal tubular cells in high glucose. J Am Soc Nephrol 2002; 13: 302-312.
49. Oldberg A, Franzen A, Heinegard D. Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell-binding sequence. Proc Natl. Acad Sci USA 1986; 83: 8819-8823.
50. Nudel U, Zakut R, Shani M et al. The nucleotide sequence of the rat cytoplasmic β-acting gene. Nucleic Acid Res 1983; 11: 1759-1771.
51. Hiseh T-J, Fustier P, Zhang S-L et al. High glucose stimulates angiotensinogen gene expression and cell hypertrophy via activation of the hexosamine biosynthesis pathway in rat kidney proximal tubular cells. Endocrinology 2003; 144: 4338-4349.